Rexford Capital’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Rexford Capital's LLY Position: Q2 2026 in Review
Rexford Capital increased its Eli Lilly (LLY) stake by 1.1% in Q2 2026, buying an estimated $19.4K and bringing the position to 1,675 shares worth $2.01M. The position accounts for 1.23% of the portfolio, ranked #14.
Rexford Capital first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Rexford Capital held 1,675 shares of Eli Lilly worth $2.01M as of Q2 2026.
- Rexford Capital bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
- Eli Lilly made up 1.23% of Rexford Capital's portfolio in Q2 2026, its #14 holding.
- Rexford Capital first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
- 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Rexford Capital's 13F filing for Q2 2026, filed 29 Jul 2026.